Guangyan Cai

11.2k total citations
338 papers, 6.8k citations indexed

About

Guangyan Cai is a scholar working on Nephrology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Guangyan Cai has authored 338 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 166 papers in Nephrology, 93 papers in Molecular Biology and 39 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Guangyan Cai's work include Chronic Kidney Disease and Diabetes (73 papers), Renal Diseases and Glomerulopathies (71 papers) and Dialysis and Renal Disease Management (39 papers). Guangyan Cai is often cited by papers focused on Chronic Kidney Disease and Diabetes (73 papers), Renal Diseases and Glomerulopathies (71 papers) and Dialysis and Renal Disease Management (39 papers). Guangyan Cai collaborates with scholars based in China, United States and United Kingdom. Guangyan Cai's co-authors include Xiangmei Chen, Quan Hong, Xuefeng Sun, Xueyuan Bai, Bo Fu, Zhe Feng, Shaoyuan Cui, Zhi-Yu Duan, Yani He and Xiangmei Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Guangyan Cai

316 papers receiving 6.7k citations

Peers

Countries citing papers authored by Guangyan Cai

Since Specialization

Citations

This map shows the geographic impact of Guangyan Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangyan Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangyan Cai more than expected).

Fields of papers citing papers by Guangyan Cai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangyan Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangyan Cai. The network helps show where Guangyan Cai may publish in the future.

Co-authorship network of co-authors of Guangyan Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Guangyan Cai. A scholar is included among the top collaborators of Guangyan Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangyan Cai. Guangyan Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neutrophil and neutrophil extracellular traps in acute kidney injury: from mechanisms to treatments 2025 ·Frontiers in Immunology ·(unknown), Wenjuan Wang, (unknown), (unknown), (unknown), (unknown), Qiuxia Han, Zhe Feng, Xiangmei Chen, Guangyan Cai	0
2	Cxcl9high macrophages recruit circulating Cxcr3+ plasmablasts into kidneys to promote pathogenesis of lupus nephritis mice 2025 ·Communications Biology ·Jing Zhao, (unknown), (unknown), (unknown), Yingjie Zhang, (unknown), (unknown), C. Li, Wanjun Shen, Qinggang Li, Guangyan Cai, Xiangmei Chen, (unknown), Xueyuan Bai	0
3	Acute kidney injury in hospitalized patients with nonmalignant pleural effusions: a retrospective cohort study 2024 ·BMC Nephrology ·(unknown), (unknown), (unknown), (unknown), Fei Liu, Zhe Feng, Xueying Cao, Li Zhang, Guangyan Cai, Xiangmei Chen, Ping Li	0
4	Neoadjuvant Camrelizumab Combined with Chemotherapy for Resectable Stage IIIA-IIIB Non-Small Cell Lung Cancer: Single Arm Phase II Study 2024 ·International Journal of Radiation OncologyBiologyPhysics ·Guangyan Cai, Kai Wang, (unknown), Jun Zhao, Zhe Wang, Xinwei Han, Hui Zhou, Conghua Xie, Fu S, Hui Jia, (unknown), Wěi Li, Fei Teng, Sheng Wang, Jinming Yu, Peng Song, Xu Meng	1
5	Clinical Presentation and Outcomes of Hospitalized Patients with Chronic Kidney Disease and COVID-19 Variant Omicron 2024 ·Therapeutics and Clinical Risk Management ·Xiaolong Wang, Xueying Cao, (unknown), Guangyan Cai	0
6	Red blood cell distribution width-to-monocyte ratio for predicting 90-day mortality of COVID-19 in patients with chronic kidney disease during the Omicron period: a prospective single-center study 2024 ·Renal Failure ·(unknown), (unknown), (unknown), Zhe Feng, Fei Liu, Yong Wang, Xueying Cao, Jie Wu, (unknown), Xuefeng Sun, Li Zhang, Guangyan Cai, (unknown), Xiangmei Chen	0
7	Fecal microbiota transplantation for the management of autoimmune diseases: Potential mechanisms and challenges 2023 ·Journal of Autoimmunity ·Xiaomin Liu, Mei Liu, Ming Zhao, Ping Li, (unknown), Xinyu Fan, Guangyan Cai, Qianjin Lu, Xiangmei Chen	12
8	Optimization strategies of mesenchymal stem cell-based therapy for acute kidney injury 2023 ·Stem Cell Research & Therapy ·(unknown), Yifan Zhang, Xiaodong Geng, Kun Chi, Chao Liu, Chengcheng Song, Guangyan Cai, Xiangmei Chen, Quan Hong	13
9	The PI3K-Akt-mTOR pathway mediates renal pericyte-myofibroblast transition by enhancing glycolysis through HKII 2023 ·Journal of Translational Medicine ·(unknown), Xiaofan Li, Yiyao Deng, Jianwen Chen, Mengjie Huang, (unknown), (unknown), Lingling Wu, Quan Hong, Zhe Feng, Guangyan Cai, Xuefeng Sun, Xueyuan Bai, Xiangmei Chen	25
10	Single-cell dissection of cellular and molecular features underlying mesenchymal stem cell therapy in ischemic acute kidney injury 2023 ·Molecular Therapy ·(unknown), Min Zhang, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Siyang Wang, Quan Hong, Zhe Feng, Xiangmei Chen, Guangyan Cai	22
11	Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis 2023 ·PeerJ ·Xia Niu, Shuyu Zhang, Chen Shao, Zhengguang Guo, Jianqiang Wu, Jianling Tao, Ke Zheng, Wenling Ye, Guangyan Cai, Wei Sun, Mingxi Li	4
12	Comparative risk of acute kidney injury among cancer patients treated with immune checkpoint inhibitors 2022 ·Cancer Communications ·Fei Liu, Zixian Wang, Xiaofan Li, Zhen Zhang, Yue Yang, Junquan Chen, (unknown), Lingling Wu, Xiangyu Liu, Sujun Han, Fangming Wang, Wasilijiang Wahafu, Yibo Gao, Shancheng Ren, Nianzeng Xing, Guangyan Cai, Xiangmei Chen	9
13	Efficacy of umbilical cord mesenchymal stem cell transfusion for the treatment of severe AKI: a protocol for a randomised controlled trial 2022 ·BMJ Open ·(unknown), Jianjun Gao, Siyang Wang, Wenjuan Wang, (unknown), Xiaolong Wang, Shuang Liang, Zhe Feng, Shupeng Lin, Li Zhang, Xiangmei Chen, Guangyan Cai	5
14	Krϋppel‐like factor 15 suppresses renal glomerular mesangial cell proliferation via enhancing P53 SUMO1 conjugation 2021 ·Journal of Cellular and Molecular Medicine ·Lingling Wu, Li Ou, (unknown), Xu Wang, Pu Chen, Guangyan Cai, Xiangmei Chen, Quan Hong	8
15	LRG1 May Accelerate the Progression of ccRCC via the TGF‐β Pathway 2020 ·BioMed Research International ·Quan Hong, Shuqiang Wang, Shuxin Liu, Xiangmei Chen, Guangyan Cai	18
16	Associations of coenzyme Q10 with endothelial function in hemodialysis patients 2020 ·Nephrology ·Jianjun Gao, (unknown), (unknown), Li Zhang, Xueying Cao, (unknown), Guangyan Cai, Xiangmei Chen	5
17	STAT3 Inhibition Partly Abolishes IL-33–Induced Bone Marrow–Derived Monocyte Phenotypic Transition into Fibroblast Precursor and Alleviates Experimental Renal Interstitial Fibrosis 2019 ·The Journal of Immunology ·(unknown), Xueyuan Bai, Quan Hong, Shaoyuan Cui, Xu Wang, Fengjun Xiao, Jin Li, Li Zhang, Zheyi Dong, Yong Wang, Guangyan Cai, Xiangmei Chen	7
18	Low-dose 2-deoxyglucose and metformin synergically inhibit proliferation of human polycystic kidney cells by modulating glucose metabolism 2019 ·Cell Death Discovery ·Jing Zhao, Yuxiang Ma, Yingjie Zhang, Bo Fu, Xiao‐Yuan Wu, Qinggang Li, Guangyan Cai, Xiangmei Chen, Xueyuan Bai	40
19	Comparative proteomic analysis of urine and laser microdissected glomeruli in IgA nephropathy 2017 ·Clinical and Experimental Pharmacology and Physiology ·(unknown), Zhong Yin, (unknown), (unknown), (unknown), Wanjun Shen, Lu Yang, Guangyan Cai, Xueguang Zhang, Xiangmei Chen	11
20	Cardiovascular metabolic risk factors and glomerular filtration rate: a rural Chinese population study 2016 ·Lipids in Health and Disease ·(unknown), Geng Qian, Wenjun Hao, Xiaodong Geng, Quan Hong, Guangyan Cai, Xiangmei Chen, Di Wu	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact